Launched in 2011, the Forbes “30 Under 30” recognizes people under the age of 30 from a wide range of industries who are making a notable impact in their field. For the Healthcare category, the recipients include entrepreneurs and researchers who are taking on some of healthcare’s biggest challenges.
Mohit Sodhi
As a graduate from UBC’s Experimental Medicine Program, and under the supervision of Dr. Mahyar Etminan, Sodhi collaborates on research that examines rare adverse events of some of the most commonly prescribed medications. In one such study, he and his colleagues identified cardiac issues from fluoroquinolone that led to regulatory agencies revising their recommendations for its use. Other studies uncovered eye damage from erectile dysfunction drugs and serious gastrointestinal side effects from GLP-1 drugs like Ozempic.
